Effect of KYG0395 on Primary Dysmenorrhea
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 213
Summary
- Conditions
- Primary Dysmenorrhea
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 35 years
- Gender
- Only males
Description
Compare the effect and safety of the investigational drug and placebo on dysmenorrhea in adult otherwise healthy women.
Compare the effect and safety of the investigational drug and placebo on dysmenorrhea in adult otherwise healthy women.
Tracking Information
- NCT #
- NCT01588236
- Collaborators
- Not Provided
- Investigators
- Study Director: Xiaoming Song, MD Jiangsu Kanion Pharmaceutical Co., Ltd
Get Well Soon